The Director-General, National Agency for Food and Drug Administration and Control (NAFDAC), Mojisola Adeyeye, said GlaxoSmithKline (GSK) Consumer Nigeria’s impending exit is not to blame for the rising costs of drugs in the country.
Adeyeye said the prices of drugs had been rising before the company announced to stop operation. She blamed the devaluation of the naira for the hike.
According to Adeyeye in a report by NAN on Saturday: “The first reason for the increment in the prices of drug is that the value of naira has depreciated.”
